1-beta-D-arabinofuranosyl-5-(2-bromovinyl)uracil,
1-beta-D-arabinofuranosyl-E-5-(2-bromovinyl)uracil,
5-(2-bromovinyl)-1-beta-D-arabinofuranosyluracil,
brovavir,
BV-ara-U,
BV-araU,
sorivudine,
SORIVUDINE,
Bravavir,
Usevir,
Brovavir,
77181-69-2,
BVAU,
BV-Ara-U,
YN-72,
Bromovinyluridine,
5-Bromovinyl-araU,
BV-araU,
Sorivudinum [INN-Latin],
SQ-32756,
Sorivudina [INN-Spanish],
UNII-C7VOZ162LV,
ARYS-01,
CCRIS 5285,
(E)-5-(2-Bromovinyl)uridine,
DRU-0136,
C7VOZ162LV,
(E)-5-(2-Bromovinyl)-1-beta-D-arabinofuranosyluracil,
CHEMBL70046,
1-beta-D-Arabinofuranosyl-(E)-5-(2-bromovinyl)uracil,
(+)-1-beta-D-Arabinofuranosyl-5-((E)-2-bromovinyl)uracil,
(E)-1-beta-D-Arabinofuranosyl-5-(2-bromoethenyl)-2,4(1H,3H)-pyrimidinedione,
1-beta-D-arabinofuranosyl-5-(2-bromovinyl)uracil,
Sorivudina,
Sorivudinum,
2,4(1H,3H)-Pyrimidinedione, 1-beta-D-arabinofuranosyl-5-(2-bromoethenyl)-, (E)-,
C11H13BrN2O6,
Bromovinyl araU,
BVaraU,
Sorivudine [USAN:BAN:INN:JAN],
Sorivudine [USAN:INN:BAN:JAN],
Bravavir (TN),
BV ara-U,
AC1NQZN1,
SCHEMBL82640,
Sorivudine (JAN/USAN/INN),
CHEBI:32152,
5-[(E)-2-bromoethenyl]-1-[(2R,3S,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidine-2,4-dione,
ZINC3653374,
BDBM50206491,
JA-001,
AKOS025149268,
DB11998,
SB18958,
SO-32756,
LS-135099,
SQ 32,756,
D01734,
5-(2-bromovinyl)-1-beta-D-arabinofuranosyluracil,
1-.beta.-D-arabinofuranosyl-5-(2-bromovinyl)uracil,
1-beta-D-arabinofuranosyl-E-5-(2-bromovinyl)uracil,
2,4(1H,3H)-Pyrimidinedione, 1-.beta.-D-arabinofuranosyl-5-[(1E)-2-bromoethenyl]-,
5-((E)-2-Bromo-vinyl)-1-((2R,3S,4S,5R)-3,4-dihydroxy-5-hydroxymethyl-tetrahydro-furan-2-yl)-4-hydroxy-1H-pyrimidin-2-one,
5-[(E)-2-bromovinyl]-1-[(2R,3S,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]pyrimidine-2,4-dione,
Usevir (TN),
D03TGJ,
C11-H13-Br-N2-O6,
CID5282192,
1-beta-D-Arabinofuranosyl-5-[(1E)-2-bromoethenyl]-2,4(1H,3H)-pyrimidinedione,